key: cord-1052121-qka8g543 authors: Vasse, Marc; Ballester, Marie‐Christine; Ayaka, Degnile; Sukhachev, Dmitry; Delcominette, Frédérique; Habarou, Florence; Jolly, Emilie; Sukhacheva, Elena; Pascreau, Tiffany; Farfour, Éric title: Interest of the cellular population data analysis as an aid in the early diagnosis of SARS‐CoV‐2 infection date: 2020-08-19 journal: Int J Lab Hematol DOI: 10.1111/ijlh.13312 sha: bae54e285a98e4dd005f1cc6688312c94a911c20 doc_id: 1052121 cord_uid: qka8g543 INTRODUCTION: Coronavirus disease 2019 (COVID‐19) is characterized by a high contagiousness requiring isolation measures. At this time, diagnosis is based on the positivity of specific RT‐PCR and/or chest computed tomography scan, which are time‐consuming and may delay diagnosis. Complete blood count (CBC) can potentially contribute to the diagnosis of COVID‐19. We studied whether the analysis of cellular population data (CPD), provided as part of CBC‐Diff analysis by the DxH 800 analyzers (Beckman Coulter), can help to identify SARS‐CoV‐2 infection. METHODS: Cellular population data of the different leukocyte subpopulations were analyzed in 137 controls, 322 patients with proven COVID‐19 (COVID+), and 285 patients for whom investigations were negative for SARS‐CoV‐2 infection (COVID−). When CPD of COVID+ were different from controls and COVID− patients, we used receiver operating characteristic analysis to test the discriminating capacity of the individual parameters. Using a random forest classifier, we developed the algorithm based on the combination of 4 monocyte CPD to discriminate COVID+ from COVID− patients. This algorithm was tested prospectively in a series of 222 patients referred to the emergency unit. RESULTS: Among the 222 patients, 86 were diagnosed as COVID‐19 and 60.5% were correctly identified using the discriminating protocol. Among the 136 COVID− patients, 10.3% were misclassified (specificity 89.7%, sensitivity 60.5%). False negatives were observed mainly in patients with a low inflammatory state whereas false positives were mainly seen in patients with sepsis. CONCLUSION: Consideration of CPD could constitute a first step and potentially aid in the early diagnosis of COVID‐19. emergency units (EmU) and has led to a shortage of isolation rooms. For correct triaging of patients, diagnostic testing is of key importance. The leading standard test for detecting SARS-CoV-2 is a RT-PCR of nasopharyngeal swab material. 3, 4 However, RT-PCR testing is time-consuming, and the shortage of testing materials and capacity imposes a serious threat. Chest computed tomography scan (CT scan) has also been proposed for the diagnosis of COVID-19, but its availability can be problematic, and it can be inconclusive in the early phase of the disease. 4 Several biological abnormalities were also described, such as leukopenia and lymphopenia. Therefore, CBC and differential (Diff) can potentially contribute to the diagnosis of COVID-19. 5 The white blood cell (WBC) differential analysis performed on Beckman Coulter hematology analyzers is based on "VCS technology." Briefly, WBC is characterized and identified by their volume "V" (measured by direct impedance), their conductivity "C" (analyzed by conductivity in radio frequency current), and their scatter "S" of a laser beam. Several reports indicated that VCS parameters, called CPD, are modified in case of infectious diseases. [6] [7] [8] [9] Therefore, we tested whether CPD are affected in cases of infection with SARS-CoV-2 and whether these variations could constitute an element for helping for the diagnosis of COVID-19. Currently, these morphometric parameters are research use only; their clinical utility has not been established. The work was divided into two parts. In a first part (March 11 to April 5, 2020), the CPD of 322 consecutive patients from the EmU with positive RT-PCR (Allplex 2019 nCoV Assay; Eurobio) were collected. The CPD of these patients were compared to those of 285 consecutive patients for whom COVID-19 was suspected by clinical examination, but who had a negative RT-PCR and for whom CT scan was not suggestive of COVID-19 infection. The CPD patient groups were analyzed in reference to a control group, composed of 137 subjects with a normal CBC and differential, referred to our institution from January 21, to February 9, 2020, without evidence of infectious diseases and when prevalence of SARS-CoV-2 was very low in France. 10 The main demographic and hematological parameters of this patient cohort are presented in Table 1 . The second part of the study was prospective: from April 6, to April 13, 2020, 400 patients came to the emergency unit and their initial evaluation included a CBC and Diff. Among them, COVID-19 was suspected in 222 cases, and a RT-PCR was performed. It was positive for 77 cases. We also included as COVID-19-positive cases, 7 patients with characteristic clinical signs and a typical CT scan whereas RT-PCR was negative and 2 cases with a characteristic CT scan in the absence of RT-PCR. Therefore, a total of 86 patients were considered COVID-19 positive, whereas 136 (out ily are informed that their biological data used for routine care may be used in an anonymous manner, unless they express their opposition). Blood was collected in 3 mL S-Monovettes (Sarstedt) containing 4.8 mg EDTA-K3. Analyses were performed within 6 hours after collection on DxH 800(Beckman Coulter, Inc.). The instrument characteristics and performances have been previously reported. 9 C-reactive protein (CRP) was quantified using Alinity CRP Vario Reagent on Alinity analyzers (Abbott Diagnostics France). First, 30% of samples were randomly selected for validation set and others were used as a test set for computation. RF was used to estimate the ability of a given set of parameters to deliver the desired tree classifier. The RF algorithm was applied several times to produce between 100 and 500 classification trees. This allows to estimate the best possible prediction power for the validation set. This technique delivers a robust estimation for all critical parameters of the decision tree construction process to provide classification accuracy for the test set and for a given set of parameters, prediction power on validation set, and relative importance of parameters for tree construction. Unfortunately, the result of RF could not be described explicitly and, therefore, be directly implemented for prediction. The result of RF is a big set of trees, not a particular tree. Secondly, using this information, we tried to compute the decision tree in Excel, which delivered similar results as the RF algorithm for the test set and validation set, respectively. Finally, we adjusted thresholds at each node to minimize the number of false-positive samples for the initial database, which includes all samples: test set, validation set, and outliers. Cellular population data of polymorphonuclear cells, lymphocytes, and monocytes were recorded. The vast majority of CPD was different among the 3 groups, and CPD of patients (with or without COVID-19) were significantly different from CPD of controls, except for MN-C-NE, MN-V-NE, and MN-LALS-LY (data not shown). As the goal of our study was to discriminate patients with COVID-19 from patients without COVID-19, we focused on CPD which were different between both groups and by ROC analysis, selected only parameters for which the AUC was above 0.6. Four, six, and nine CPD fulfilled these criteria, for NE, LY, and MO, respectively, (Table 2) . Therefore, monocytes CPD were clearly the most affected by SARS- Table 3 . Most of the cases were sepsis or infections. Second Diagnosis of COVID-19 is complex, first because it is a new pathology whose clinical signs seem to be highly variable and nonspecific, some patients being asymptomatic. 1 for this type of test. 12, 13 Chest CT scan has been proposed in patients in whom RT-PCR was negative despite a high clinical suspicion of COVID-19, but it can be negative in the early phases of the pathology. 4 Lastly, both tests are quite expensive, require some time to be carried out, and are not available in all hospital structures, while precautions must be taken to isolate the patient due to the high contagiousness of the virus. Thereby, different approaches have been proposed to identify patients with SARS-CoV-2 infection based on routine biological tests. CBC and Diff constitute a part of these routine assays. 14, 15 As it has been shown that CPD could contribute to the diagnosis of different infectious pathologies, [6] [7] [8] [9] we wondered if the CPDs were modified Therefore, we built and tested a discriminating protocol, based on monocytes CPD, in order to identify patients with a possible SARS-CoV-2 infection. Our aim was to develop the algorithm which can be implemented as decision rules on our routine hematology analyzer, DxH 800. The specificity was 89.7%, and the sensitivity was 60.5%, comparable to that of the other tests currently offered: sensitivity of RT-PCR varied between 63% and 78%, 16 and a recent meta-analysis of CT scan described a pooled sensitivity of 94.6%, but a low specificity (46%). 17 The main advantage of this methodology is that it gives a rapid answer and is free since it is an integral part of the CBC and Diff from the Beckman Coulter analyzer. Most of the cases of false positives were due to sepsis. This was observed in a series of patients from which the blood had been drawn in last autumn 2019, when SARS-CoV-2 infections were nonexistent in France. This is not surprising, since variations of monocytes CPD were shown to be of interest for the identification, in EmU, of patients with sepsis.. 6, 8, 9 However, clinical profiles are different for patients with sepsis, and therefore, these false positives can be eliminated by the clinicians and the flag given by the analyzer with CBC-Diff result must be taken within the clinical context of each individual patient. During winter, in the northern hemisphere, flu, due to another respiratory virus, is frequent. To our knowledge, variations of CPD on DxH800 of patients infected by influenza virus were not reported. We performed a retrospective study in our institution and also observed similar variations in the parameters used in our discriminating protocol, but the increase in SD-UMALS-MO was less pronounced than in patients with COVID-19 (data not shown). At this time, we therefore cannot exclude that our discriminating protocol would be less efficient when both viruses can be present, but the pattern of WBC differential results is different between patients with flu and patients with COVID-19. Indeed, in agreement with others, 18 we observed a higher monocyte count in patients with flu, while monocytes count is usually normal in patients with Another limitation of this study is that CPD levels on DxH 800 are not standardized on different hematology analyzers, therefore the cutoff proposed by this algorithm must be adapted for each lab- oratory. An external control to calibrate CPD would be very helpful to use CPD levels in routine and make possible a multicentric evaluation of this protocol. Another limitation is the identification of patients without COVID-19 considered for the discriminating protocols. We selected patients with a negative RT-PCR (in some cases, this test was performed twice) and negative CT scan, when available, but because of the sensitivity of these tests, as well as the versatility of the clinical signs, we cannot exclude that some patients considered negative actually suffered from the SARS-CoV-2 infection, therefore limiting the power of the discriminating protocol. In contrast, the characteristics of the population of patients COVID + are clearly like that previously described in terms of age, gender, lower lymphocyte, eosinophils, and platelet counts. 20 This preliminary study suggests that consideration of CPD could constitute a first step and potentially aid in the early diagnosis of COVID-19 in the EmU. Its use can be beneficial to developing countries and, in those countries, suffering from a shortage of RT-PCR reagents and/or specialized laboratories as an inexpensive and available alternative to identify potential COVID-19 patients. MV, ES, TP, and EF. conceived the study and designed experimental procedures; MCB recruited patients, DA, FD, FH, EJ, and EF collected patients' data; MV, ES, and DS performed statistical analysis; MV and ES wrote the paper. All authors reviewed and approved the final version. Beckman-Coulter company. Marc Vasse https://orcid.org/0000-0002-8784-7209 Elena Sukhacheva https://orcid.org/0000-0002-2854-4742 Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Clinical characteristics of coronavirus disease 2019 in China Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city Screening of sepsis using leukocyte cell population data from the Coulter automatic blood cell analyzer DxH800 Evaluation of cell population data on the UniCel DxH 800 Coulter Cellular Analysis system as a screening for viral infection in children Improved early detection of sepsis in the ED with a novel monocyte distribution width biomarker Evaluation of new laboratory tests to discriminate bacterial from nonbacterial chronic obstructive pulmonary disease exacerbations SARS-COV-2 was already spreading in France in late The new haematology analyzer DxH 800: an evaluation of the analytical performances and leucocyte flags, comparison with the LH 755 Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: rather than recurrence Laboratory parameters in detection of COVID-19 patients with positive RT-PCR; a diagnostic accuracy study Routine blood tests as a potential diagnostic tool for COVID-19 The appropriate use of testing for COVID-19 Systematic review and meta-analysis on the value of chest CT in the diagnosis of coronavirus Disease (COVID-19): Sol Scientiae Illustra Nos Differentiating between 2019 novel coronavirus pneumonia and influenza using a nonspecific laboratory marker-based dynamic nomogram Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China Hematological findings and complications of COVID-19